Ok, Got the ARDS update page - I'd say still heavily hedged, and rightfully so - the waiting period is still in effect. They say in the asterisks text that it's subject to terms and conditions, as well as using language like "anticipated" which means Novartis will decide after analysing the ARDS data. This is like buying a house and doing a building and pest inspection before you sign - it'll only ruin the sale if they think Rem-L won't work at all.
Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-568
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |